NCT07733063Recruiting
Serum Ferroptosis Biomarkers (GPX4, MDA) in Alopecia Areata
Evaluation of Serum Ferroptosis Biomarkers (GPX4 and MDA) and Their Relationship With Disease Stage, Clinical Severity, and Trichoscopic Findings in Patients With Alopecia Areata
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Recruiting
- Declared phase
- No phase declared
- Sponsor
- Istanbul Training and Research Hospital
- Participants (registry)
- 156
- Start
- June 2026
- Primary completion
- December 2026 (planned)
- Study completion
- January 2027 (planned)
- Last registry update
- July 2026
- Countries
- Turkey
Conditions studied: Alopecia Areata(AA), Alopecia Areata, Alopecia Areata (& Ophiasis), Alopecia
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.